“…A role for C/ EBPs in the regulation of differentiation, proliferation, as well as in inflammation and immunological defenses in other organs and tissues is well established (Poli, 1998;Diamond et al, 2000;Musikacharoen et al, 2001;Ramji and Foka, 2002;Cassel and Nord, 2003), and an increasing amount of evidence implicates C/EBPs in lung diseases (Halmos et al, 2002;Roth et al, 2004;Didon et al, 2005Didon et al, , 2010Didon et al, , 2011Binia et al, 2011). We have previously observed reduced activity of C/EBPb in smokers with chronic obstructive pulmonary disease (COPD) (Didon et al, 2005) as well as reduced expression of C/EBPb in cigarette smokers (Didon et al, 2011), indicating a role for C/ EBPs in COPD pathogenesis. In addition, defective C/EBPa signaling is associated with dysfunctional lung maturation (Basseres et al, 2006;Berg et al, 2006;Martis et al, 2006;Didon et al, 2010), reminiscent of the pulmonary immaturity of premature children with bronchopulmonary dysplasia, which may contribute to obstructive symptoms later in life (Vrijlandt et al, 2006;Lum et al, 2011).…”